A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence

Drug and Alcohol Dependence

Volumn 155, Issue , 2015, Pages 105-110

  Kampman, Kyle M ^a   Lynch, Kevin G ^a   Pettinati, Helen M ^a   Spratt, Kelly ^b   Wierzbicki, Michael R ^a   Dackis, Charles ^a   O'Brien, Charles P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alcohol; Clinical trial; Cocaine; Modafinil; Placebo

Indexed keywords

MODAFINIL; PLACEBO; BENZHYDRYL DERIVATIVE; BENZOYLECGONINE; COCAINE;

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; TREATMENT DURATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; ADOLESCENT; ANALOGS AND DERIVATIVES; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; CRAVING; DRUG EFFECTS; MEDICATION COMPLIANCE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; ALCOHOLISM; BENZHYDRYL COMPOUNDS; COCAINE; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CRAVING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941942783     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.08.005     Document Type: Article

References (28)

1. Alterman A.I., McKay J.R., Mulvaney F.D., McLellan A.T. Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug Alcohol Depend. 1996, 40:227-233.
2. Anderson A.L., Li S.H., Biswas K., McSherry F., Holmes T., Iturriaga E., Kahn R., Chiang N., Beresford T., Campbell J., Haning W., Mawhinney J., McCann M., Rawson R., Stock C., Weis D., Yu E., Elkashef A.M. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2009, 120:135-141.
3. Baker D., McFarland K., Lake R., Shen H., Toda S., Kalivas P. N-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Ann. N.Y. Acad. Sci. 2003, 1003:349-351.
4. Carroll K.M. Behavioral therapies for co-occurring substance use and mood disorders. Biol. Psychiatry 2004, 56:778-784.
5. Dackis C., O'Brien C. Glutamatergic agents for cocaine dependence. Ann. N.Y. Acad. Sci. 2003, 1003:328-345.
6. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005, 30:205-211.
7. Dackis C.A., Kampman K.M., Lynch K.G., Plebani J.G., Pettinati H.M., Sparkman T., O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J. Subst. Abuse Treat. 2012, 43:303-312.
8. Dackis C.A., Lynch K.G., Yu E., Samaha F.F., Kampman K.M., Cornish J.W., Rowan A., Poole S., White L., O'Brien C.P. Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend. 2003, 70:29-37.
9. Diggle P., Heagerty P., Liang K., Zeger S. Analysis of Longitudinal Data 2002, Oxford University Press.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-IP, Version 2.0) 1996, Biometrics Research Department, New York State Psychiatric Institute, New York.
11. Grant B.F., Harford T.C. Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend. 1990, 25:97-104.
12. Assessment Manual for Psychopharmacology: Publication ADM 76-338 1976, US Department of Health Education and Welfare, Washington, DC. W. Guy (Ed.).
13. Hart C.L., Haney M., Vosburg S.K., Rubin E., Foltin R.W. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 2008, 33:761-768.
14. Kadden R., Carroll K.M., Donovan D., Cooney N., Monti P., Abrams D., Litt M., Hester R. Cognitive Behavioral Coping Skills Manual 1992, U.S. Governmmet Printing Office, Washington, DC.
15. Kampman K.M., Alterman A.I., Volpicelli J.R., Maany I., Muller E.S., Luce D.D., Mulholland E.M., Jawad A.F., Parikh G.A., Mulvaney F.D., Weinrieb R.M., O'Brien C.P. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol. Addict. Behav. 2001, 15:52-59.
16. Kampman K.M., Volpicelli J.R., McGinnis D.E., Alterman A.I., Weinieb R.M., D'Angelo L.D., Epperson L. Reliability and validity of the cocaine selective severity assessment. Addict. Behav. 1998, 23:49-461.
17. Malcolm R., Swayngim K., Donovan J.L., DeVane C.L., Elkashef A., Chiang N., Khan R., Mojsiak J., Myrick D.L., Hedden S., Cochran K., Woolson R.F. Modafinil and cocaine interactions. Am. J. Drug Alcohol Abuse 2006, 32:577-587.
18. McCance-Katz E.F., Kosten T.R., Jatlow P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone - a multiple-dose study. Biol. Psychiatry 1998, 44:250-259.
19. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 1992, 9:199-213.
20. Molenberghs G., Verbeke G. Models for Discrete Longitudinal Data 2005, Springer, New York.
21. SAMHSA Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863, Rockville MD 2014.
22. Schmitz J.M., Green C.E., Stotts A.L., Lindsay J.A., Rathnayaka N.S., Grabowski J., Moeller F.G. A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone. Drug Alcohol Depend. 2014, 136:100-107.
23. Schmitz J.M., Rathnayaka N., Green C.E., Moeller F.G., Dougherty A.E., Grabowski J. Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation. Front. Psychiatry 2012, 3:1-7.
24. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20). 22-33;quiz 34-57.
25. Sobell L.C., Sobell M.B. Alcohol Timeline Followback Users' Manual 1995, Addiction research Foundation, Toronto.
26. Somoza E., Dyrenforth S., Goldsmith J., Mezinskis J., Cohen M. In search of a universal drug craving scale. Annual Meeting of the American Psychiatric Association 1995.
27. Touret M., Sallanon-Moulin M., Fages C., Roudier V., Didier-Bazes M., Roussel B., Tardy M., Jouvet M. Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain. Brain Res. Mol. Brain Res. 1994, 26:123-128.
28. Volkow N.D., Fowler J.S., Logan J., Alexoff D., Zhu W., Telang F., Wang G.J., Jayne M., Hooker J.M., Wong C., Hubbard B., Carter P., Warner D., King P., Shea C., Xu Y., Muench L., Apelskog-Torres K. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 2009, 301:1148-1154.